Researchers reviewed 11 studies on ancient virus-like DNA fragments buried in the human genome, finding that one type correlates with better immune response and survival in pancreatic cancer patients.
1
Analysis pooled 11 studies covering 1,085 pancreatic cancer cases among 9,241 total cancer patients
2
HERV detection rates ranged from 16.7% to about 80% depending on the sequence and lab method used
3
HERV-H derived HHLA2 was linked to increased CD8+ T-cell infiltration and favorable survival (HR 0.47-0.66), while other markers showed adverse associations (HR 1.26-2.24)
mail
Weekly plant science — one email, Saturdays.
Check your inbox to confirm — link expires in 24 hours.
Something went wrong — please try again.
Too many signup attempts from your network. Try again in an hour, or email hello@plant.news.